Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Academic Appointments
Last Updated 5/6/2024
University Of Texas Medical School At San Antonio - San Antonio TX
Rank:
Full Professor
Years:
1999-2011
University Of Texas Medical School At San Antonio - San Antonio TX
Rank:
Adjunct Professor
Years:
2011-current
Georgetown University School Of Medicine - Washington DC
Rank:
Adjunct Professor
Years:
2012-present
Publications
(up to ten in the last five years)
Last Updated 5/6/2024
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
J Clin Oncol.
Volume: 27
Date: 07 2009
www.ncbi.nlm.nih.gov/pmc/articles/PMC2734394/?tool=pubmed
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.
Clin Cancer Res.
Volume: 15
Date: 08 2009
www.ncbi.nlm.nih.gov/pmc/articles/PMC2745926/?tool=pubmed
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
Fertil Steril.
Volume: 92
Date: 09 2009
www.ncbi.nlm.nih.gov/pubmed/19635613
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897.
J Clin Oncol
Volume: 27
Date: 10 2009
www.ncbi.nlm.nih.gov/pubmed/19752340
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Lancet Oncol
Volume: 11
Date: 01 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC3058239/?tool=pubmed
Molecular profiling of endometrial malignancies.
Obstet Gynecol Int
Date: 03 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC2846683/?tool=pubmed
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome
Am J Pathol
Volume: 176
Date: 04 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC2843456/?tool=pubmed
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells
Cancer Res.
Volume: 70
Date: 05 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC2889925/?tool=pubmed
Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
BMC Cancer
Volume: 10
Date: 07 2010
www.ncbi.nlm.nih.gov/pmc/articles/PMC2915985/?tool=pubmed
Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer
Clin Cancer Res
Volume: 16
Date: 12 2010
www.ncbi.nlm.nih.gov/pubmed/21169260